Ruiwen Zhang to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Ruiwen Zhang has written about Drug Screening Assays, Antitumor.
Connection Strength
0.308
-
Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy. Cancer Res. 2018 10 01; 78(19):5656-5667.
Score: 0.155
-
Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms. Carcinogenesis. 2018 07 30; 39(8):1026-1036.
Score: 0.153